BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25618752)

  • 21. Utility of homoarginine in the GC-MS quantification of asymmetric dimethylarginine (ADMA) in human serum proteins.
    Bollenbach A; Hanff E; Tsikas D
    Anal Biochem; 2018 Dec; 563():67-70. PubMed ID: 30312621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
    Davids M; Teerlink T
    Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
    Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?
    Işıklar OO; Barutcuoğlu B; Kabaroğlu C; Mutaf I; Özmen D; Bayındır O; Zoghi M; Uluer H
    Clin Biochem; 2012 Nov; 45(16-17):1325-30. PubMed ID: 22750146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homoarginine, arginine, and relatives: analysis, metabolism, transport, physiology, and pathology.
    Tsikas D; Wu G
    Amino Acids; 2015 Sep; 47(9):1697-702. PubMed ID: 26210755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markers of nitric oxide are associated with sepsis severity: an observational study.
    Winkler MS; Kluge S; Holzmann M; Moritz E; Robbe L; Bauer A; Zahrte C; Priefler M; Schwedhelm E; Böger RH; Goetz AE; Nierhaus A; Zoellner C
    Crit Care; 2017 Jul; 21(1):189. PubMed ID: 28709458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG; Aasarød KI; Sagen E; Åsberg A
    Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic oral L-arginine administration on the L-arginine/NO pathway in patients with peripheral arterial occlusive disease or coronary artery disease: L-Arginine prevents renal loss of nitrite, the major NO reservoir.
    Schneider JY; Rothmann S; Schröder F; Langen J; Lücke T; Mariotti F; Huneau JF; Frölich JC; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1961-74. PubMed ID: 26123989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of unlabeled and stable isotope-labeled homoarginine, arginine and their metabolites in biological samples by GC-MS and GC-MS/MS.
    Kayacelebi AA; Knöfel AK; Beckmann B; Hanff E; Warnecke G; Tsikas D
    Amino Acids; 2015 Sep; 47(9):2023-34. PubMed ID: 25957527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GC-MS and GC-MS/MS measurement of the cardiovascular risk factor homoarginine in biological samples.
    Kayacelebi AA; Beckmann B; Gutzki FM; Jordan J; Tsikas D
    Amino Acids; 2014 Sep; 46(9):2205-17. PubMed ID: 24923265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opposing effects of rheumatoid arthritis and low dose prednisolone on arginine metabolomics.
    Radhakutty A; Mangelsdorf BL; Drake SM; Rowland A; Smith MD; Mangoni AA; Thompson CH; Burt MG
    Atherosclerosis; 2017 Nov; 266():190-195. PubMed ID: 29035782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum concentrations of L-arginine and L-homoarginine in male patients with intermittent claudication: a cross-sectional and prospective investigation in the CAVASIC Study.
    Vogl L; Pohlhammer J; Meinitzer A; Rantner B; Stadler M; Peric S; Hammerer-Lercher A; Klein-Weigel P; Fraedrich G; Kronenberg F; Kollerits B
    Atherosclerosis; 2015 Apr; 239(2):607-14. PubMed ID: 25746168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
    Atzler D; Schwedhelm E; Nauck M; Ittermann T; Böger RH; Friedrich N
    Clin Chem Lab Med; 2014 Dec; 52(12):1835-42. PubMed ID: 24945429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal asymmetric dimethylarginine/nitric oxide balance in patients with documented coronary artery disease: relation to renal function and homocysteine.
    Ilhan N; Seckin D; Ilhan N; Ozbay Y
    J Thromb Thrombolysis; 2007 Jun; 23(3):205-11. PubMed ID: 17160550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral supplementation with L-homoarginine in young volunteers.
    Atzler D; Schönhoff M; Cordts K; Ortland I; Hoppe J; Hummel FC; Gerloff C; Jaehde U; Jagodzinski A; Böger RH; Choe CU; Schwedhelm E
    Br J Clin Pharmacol; 2016 Dec; 82(6):1477-1485. PubMed ID: 27434056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arginine derivatives in atrial fibrillation progression phenotypes.
    Büttner P; Bahls M; Böger RH; Hindricks G; Thiele H; Schwedhelm E; Kornej J
    J Mol Med (Berl); 2020 Jul; 98(7):999-1008. PubMed ID: 32504111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
    Nanayakkara PW; Kiefte-de Jong JC; ter Wee PM; Stehouwer CD; van Ittersum FJ; Olthof MR; Teerlink T; Twisk JW; van Guldener C; Smulders YM
    Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease.
    Wolf C; Lorenzen JM; Stein S; Tsikas D; Störk S; Weidemann F; Ertl G; Anker SD; Bauersachs J; Thum T
    Int J Cardiol; 2012 May; 156(3):289-94. PubMed ID: 21159392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of combined supplementation with B vitamins and antioxidants on plasma levels of asymmetric dimethylarginine (ADMA) in subjects with elevated risk for cardiovascular disease.
    Schmitt B; Wolters M; Kressel G; Hülsmann O; Ströhle A; Kühn-Velten WN; Lichtinghagen R; Bub A; Barth SW; Stichtenoth DO; Hahn A
    Atherosclerosis; 2007 Jul; 193(1):168-76. PubMed ID: 16876171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.